1. Mou, Kuanhou, Zhang, Jian, Mu, Xin, Liu, Wenli, Ge, Rui. 2021. Zwint facilitates melanoma progression by promoting c-Myc expression. In Experimental and therapeutic medicine, 22, 818. doi:10.3892/etm.2021.10250. https://pubmed.ncbi.nlm.nih.gov/34131441/
2. Lin, Tong, Zhang, Yingzhao, Lin, Zhimei, Peng, Lisheng. 2021. ZWINT is a Promising Therapeutic Biomarker Associated with the Immune Microenvironment of Hepatocellular Carcinoma. In International journal of general medicine, 14, 7487-7501. doi:10.2147/IJGM.S340057. https://pubmed.ncbi.nlm.nih.gov/34744456/
3. Li, Wen, Feng, Shan-Shan, Wu, Hao, Liu, Xiang, Chen, Zhu. 2022. Comprehensive Analysis of CDK1-Associated ceRNA Network Revealing the Key Pathways LINC00460/LINC00525-Hsa-Mir-338-FAM111/ZWINT as Prognostic Biomarkers in Lung Adenocarcinoma Combined with Experiments. In Cells, 11, . doi:10.3390/cells11071220. https://pubmed.ncbi.nlm.nih.gov/35406786/
4. Shao, Ming-Tao, Hu, Yang-Zhi, Ding, Hui, Zhao, Xiao-Xu, Pan, Yun-Long. . The overexpression of ZWINT in integrated bioinformatics analysis forecasts poor prognosis in breast cancer. In Translational cancer research, 9, 187-193. doi:10.21037/tcr.2019.12.66. https://pubmed.ncbi.nlm.nih.gov/35117172/
5. Peng, Fang, Li, Qiang, Niu, Shao-Qing, Chen, Ming, Bao, Yong. 2019. ZWINT is the next potential target for lung cancer therapy. In Journal of cancer research and clinical oncology, 145, 661-673. doi:10.1007/s00432-018-2823-1. https://pubmed.ncbi.nlm.nih.gov/30643969/
6. Akabane, Shintaro, Oue, Naohide, Sekino, Yohei, Ohdan, Hideki, Yasui, Wataru. 2021. KIFC1 regulates ZWINT to promote tumor progression and spheroid formation in colorectal cancer. In Pathology international, 71, 441-452. doi:10.1111/pin.13098. https://pubmed.ncbi.nlm.nih.gov/33819373/